Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vasee S Moorthy

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Vaccine|April 20, 2013
Malaria vaccine R&D in the Decade of Vaccines: breakthroughs, challenges and opportunitiesAshley J Birkett, Vasee S Moorthy, Christian Loucq, et al.
Vaccine|March 18, 2017
Meeting report: WHO consultation on Respiratory Syncytial Virus (RSV) vaccine development, Geneva, 25-26 April 2016Birgitte K Giersing, Ruth A Karron, Johan Vekemans, et al.
Vaccine|April 25, 2016
The 2016 Vaccine Development Pipeline: A special issue from the World Health Organization Product Development for Vaccine Advisory Committee (PDVAC)Birgitte K Giersing, Kayvon Modjarrad, David C Kaslow, et al.
Plos Medicine|January 6, 2016
Developing Global Norms for Sharing Data and Results during Public Health EmergenciesKayvon Modjarrad, Vasee S Moorthy, Piers Millett, et al.
Vaccine|July 30, 2009
Guidance on the evaluation of Plasmodium vivax vaccines in populations exposed to natural infectionIvo Mueller, Vasee S Moorthy, Graham V Brown, et al.
Vaccine|September 19, 2009
Priorities in research and development of vaccines against Plasmodium vivax malariaGraham V Brown, Vasee S Moorthy, Zarifah Reed, et al.
Nature Medicine|July 9, 2016
A roadmap for MERS-CoV research and product development: report from a World Health Organization consultationKayvon Modjarrad, Vasee S Moorthy, Peter Ben Embarek, et al.
Bulletin of the World Health Organization|May 9, 2017
Progress in promoting data sharing in public health emergenciesKatherine Littler, Wee-Ming Boon, Gail Carson, et al.
Vaccine|February 8, 2011
Towards validated assays for key immunological outcomes in malaria vaccine development, David R Cavanagh, Patrice M Dubois, et al.
The Journal of Infectious Diseases|June 8, 2004
Phase 1 evaluation of 3 highly immunogenic prime-boost regimens, including a 12-month reboosting vaccination, for malaria vaccination in Gambian menVasee S Moorthy, Egeruan B Imoukhuede, Sheila Keating, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Vaccine|April 20, 2013
Malaria vaccine R&D in the Decade of Vaccines: breakthroughs, challenges and opportunitiesAshley J Birkett, Vasee S Moorthy, Christian Loucq, et al.
Vaccine|March 18, 2017
Meeting report: WHO consultation on Respiratory Syncytial Virus (RSV) vaccine development, Geneva, 25-26 April 2016Birgitte K Giersing, Ruth A Karron, Johan Vekemans, et al.
Vaccine|April 25, 2016
The 2016 Vaccine Development Pipeline: A special issue from the World Health Organization Product Development for Vaccine Advisory Committee (PDVAC)Birgitte K Giersing, Kayvon Modjarrad, David C Kaslow, et al.
Plos Medicine|January 6, 2016
Developing Global Norms for Sharing Data and Results during Public Health EmergenciesKayvon Modjarrad, Vasee S Moorthy, Piers Millett, et al.
Vaccine|July 30, 2009
Guidance on the evaluation of Plasmodium vivax vaccines in populations exposed to natural infectionIvo Mueller, Vasee S Moorthy, Graham V Brown, et al.
Vaccine|September 19, 2009
Priorities in research and development of vaccines against Plasmodium vivax malariaGraham V Brown, Vasee S Moorthy, Zarifah Reed, et al.
Nature Medicine|July 9, 2016
A roadmap for MERS-CoV research and product development: report from a World Health Organization consultationKayvon Modjarrad, Vasee S Moorthy, Peter Ben Embarek, et al.
Bulletin of the World Health Organization|May 9, 2017
Progress in promoting data sharing in public health emergenciesKatherine Littler, Wee-Ming Boon, Gail Carson, et al.
Vaccine|February 8, 2011
Towards validated assays for key immunological outcomes in malaria vaccine development, David R Cavanagh, Patrice M Dubois, et al.
The Journal of Infectious Diseases|June 8, 2004
Phase 1 evaluation of 3 highly immunogenic prime-boost regimens, including a 12-month reboosting vaccination, for malaria vaccination in Gambian menVasee S Moorthy, Egeruan B Imoukhuede, Sheila Keating, et al.
Pageof 5